Pharmaceutical intermediates
Valbenazine Tosylate (NBI-98854) Intermediates
2 pharmaceutical intermediates for Valbenazine Tosylate (NBI-98854). Indication: Huntington's chorea; Tardive dyskinesia.
About Valbenazine Tosylate (NBI-98854)
- Originator
- Neurocrine Biosciences Inc
- Indication
- Huntington's chorea; Tardive dyskinesia
- Approved Date
- 04/11/2017
- DS/DP
- 11/08/2027
Available intermediates
2 intermediates currently listed for Valbenazine Tosylate (NBI-98854). Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| 2H-Benzo[a]quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-, (3R,11bR)- | 1026016-83-0 | / | / |
| [2R-(2a,3b,11bb)]-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-ol | 85081-18-1 | / | / |
Building toward Valbenazine Tosylate (NBI-98854)?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →